EWX holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 99.55% at a quoted market price (level 1), 34 issuer countries, 3.62% restricted securities.

EWX's largest investment is Macronix International Co Ltd at 0.71% of net assets. Kinsus Interconnect Technology Corp and WinWay Technology Co Ltd follow; the three together are 2%. Ten companies are 4.67% of the fund; the other 3,348 share the rest. Among the 721 equity funds measured here, EWX behaves like 1201 holdings against a median of 42.4 — 28.3 times the median. Across 28 quarterly filings EWX has become less concentrated: it behaved like 879.8 at 2019-09-30 and 1201 at 2026-06-30. Between the 2026-03-31 and 2026-06-30 filings 7 positions were added and 40 dropped; 13.5% of the weight moved. Taiwan is the largest country at 32.23% of the portfolio, across 34 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-09-30 and 2026-06-30, EWX went from behaving like 879.8 equally weighted positions to 1201 — 37% more, while its top ten went from 3.47% to 4.67% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

EWX's filing lists 3,359 positions including 1.88% of net assets in securities-lending cash collateral. Counted as filed the fund reads 842.5 effective holdings with a top ten of 6.23%; on its own investments — the figure above — it reads 1201 with a top ten of 4.67%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 3,358 positions in EWX's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: listed with the point-in-time files, available on request.

Share of EWX's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of EWX's own filings, 84 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: EWX.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-06-30, $123m was out to 25 borrowers, 16.77% of net assets. The largest, Barclays Capital Securities Ltd., held 37% of it.

Cash collateral reported against the loan: 1.88% of net assets, 11.2% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter EWX has filed, with each borrower: EWX.json · all funds.

3,386 positions became 3,353: 7 added (0.1% of the fund at the later date), 40 dropped (0.6% at the earlier date). Half the sum of all weight changes, a turnover proxy: 13.5%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of EWX compared this way, as a feed: changes.xml · all funds: filings received.

New: Bradsaude S A (0.06%), Creotech Quantum SA (0.01%), WellCell Holdings Co Ltd (0.01%), Orizon Valorizacao de Residuos SA (0.01%), Syn2bio SA (0.01%), Karmarts PCL (0.00%). Gone: WellCell Holdings Co Ltd (0.11%), Odontoprev SA (0.06%), Gujarat State Petronet Ltd (0.05%), Sincere Navigation Corp (0.03%), Shenzhen Neptunus Bioengineering Co Ltd (0.03%), HuBei NengTer Technology Co Ltd (0.02%).

99.5% of EWX is carried at a quoted market price (fair-value level 1); 0.0% at level 3, priced from the filer's own inputs. Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $733M. Notional of an interest-rate or currency swap is not equity exposure.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of EWX (1201). Same filings, same arithmetic. Position in this list says nothing about which fund is better.